PARIS -- France's anti-doping agency accused Lance Armstrong of violating its rules Thursday for not fully cooperating with a drug tester and says it could punish the seven-time Tour de France ...

Fatty liver disease (FLD) occurs when excess fat builds up in the liver, impairing its function. Medically known as hepatic steatosis, the condition is often silent in its early stages but can lead to ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The French anti-doping agency (AFLD) in charge of contols at the Tour de France will share its pre-Tour test results with the Union Cycliste International (UCI) despite the deep rift between the Tour ...

Refraining from drinking alcohol can help stop alcoholic fatty liver disease (AFLD) from progressing and potentially reverse the condition. AFLD is liver damage resulting from excess alcohol ...

Fatty liver disease has become one of the most common liver problems across the world. Two forms stand out: non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD). Both ...

Alcoholic liver disease is a leading cause of morbidity and mortality worldwide. Alcoholic fatty liver disease (AFLD) is a consequence of excessive alcohol consumption. When patients continue to drink ...

Many factors influence a person’s fatty liver to cirrhosis timeline. It may take several years for different types of fatty liver to turn into cirrhosis. Fatty liver disease is a condition where fat ...

The French anti-doping agency (AFLD) could cease to exist if the nation's government does not provide the necessary funding for its continuation in 2010, according to the agency's president, Pierre ...

Lance Armstrong will participate in the Tour de France after France's anti-doping agency said it will not seek sanctions over a dispute with a drug tester. The AFLD agency said in a statement that it ...